The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease

American Journal of Surgery

Volumn 199, Issue 3, 2010, Pages 294-298

  Jin, Judy ^a   Machekano, Rhoderick ^a   McHenry, Christopher R ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Predictive factor; Thyroid malignancy; Thyroid stimulating hormone

Indexed keywords

THYROTROPIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CONCENTRATION (PARAMETERS); CYTOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NODULAR THYROID DISEASE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; THYROID DISEASE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN;

EID: 77649308577     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.08.028     Document Type: Article

References (16)

1. Vander J.B., Gaston E.A., and Dawber T.R. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69 (1968) 537-540
2. Eng C. Familial papillary thyroid cancer-many syndromes, too many genes?. J Clin Endocrinol Metab 85 (2000) 1755-1757
3. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. J Am Med Assoc 295 (2006) 2164-2167
4. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
5. Papini E., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87 (2002) 1941-1946
6. Cappelli C., Pirola I., Cumetti D., et al. Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology?. Clin Endocrinol (Oxf) 63 (2005) 689-693
7. Boelaert K., et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91 (2006) 4295-4301
8. Haymart M.R. Understanding the relationship between age and thyroid cancer. Oncologist 14 (2009) 216-221
9. Haymart MR, et al. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. In: Endocrinol, C, (ed.). Oxford, 2008.
10. Polyzos S.A., et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134 (2008) 953-960
11. Pujol P., et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81 (1996) 4318-4323
12. Mann K. Evaluation of risk in autonomously functioning thyroid nodules. Exp Clin Endocrinol Diabetes 106 suppl 4 (1998) S23-S26
13. Hegedus L., Bonnema S.J., and Bennedbaek F.N. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24 (2003) 102-132
14. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 351 (2004) 1764-1771
15. McHenry C.R., Huh E.S., and Machekano R.N. Is nodule size an independent predictor of thyroid malignancy?. Surgery 144 (2008) 1062-1068
16. Belfiore A., et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93 (1992) 363-369